Hartford Insurance (HIG) president logs option grant, exercise and share sale

Rhea-AI Filing Summary

Hartford Insurance Group president Adin M. Tooker reported option and stock transactions in company shares. On February 25, 2026, he exercised 8,307 stock options at a price of $53.81 per share into common stock and then sold 8,307 common shares at $140.54 per share in an open-market transaction. These trades were made under a pre-established Rule 10b5-1 trading plan adopted on August 25, 2025. On February 24, 2026, he also received a grant of 28,982 stock options. After these transactions, his directly held common stock position was 38,208.27 shares, with multiple option awards remaining outstanding on the disclosed vesting schedules.

Insider Trade Summary

Net Seller: 8,307 shares ($1,167,466)

Net Sell 11 txns

Insider TOOKER ADIN M

Role President

Sold 8,307 shs ($1.17M)

Type	Security	Shares	Price	Value
Exercise	Stock Option	8,307	$0.00	--
Exercise	Common Stock	8,307	$53.81	$447K
Sale	Common Stock	8,307	$140.54	$1.17M
Grant/Award	Stock Option	28,982	$0.00	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Stock Option — 8,307 shares (Direct); Common Stock — 46,515.27 shares (Direct)

Footnotes (1)

1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TOOKER ADIN M

(Last) (First) (Middle)

ONE HARTFORD PLAZA

(Street)

HARTFORD CT 06155

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HARTFORD INSURANCE GROUP, INC. [ HIG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		M		8,307	A	$53.81	46,515.27	D
Common Stock	02/25/2026		S(1)		8,307	D	$140.54	38,208.27	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$140.54	02/24/2026		A		28,982		(2)	02/24/2036	Common Stock	28,982	$0.0000	28,982	D
Stock Option	$53.81	02/25/2026		M			8,307	(3)	02/27/2028	Common Stock	8,307	$0.0000	8,307	D
Stock Option	$49.01							(4)	02/26/2029	Common Stock	26,687		26,687	D
Stock Option	$51.87							(5)	02/23/2031	Common Stock	25,202		25,202	D
Stock Option	$55.27							(6)	02/25/2030	Common Stock	24,094		24,094	D
Stock Option	$69.41							(7)	02/23/2032	Common Stock	24,155		24,155	D
Stock Option	$78.28							(8)	02/28/2033	Common Stock	24,301		24,301	D
Stock Option	$95.74							(9)	02/27/2034	Common Stock	16,492		16,492	D
Stock Option	$116.41							(10)	02/25/2035	Common Stock	25,488		25,488	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

2. One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.

3. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.

4. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.

5. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.

6. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.

7. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.

8. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.

9. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.

10. One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

	Anthony J. Salerno, Jr., Attorney-in-Fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did HIG president Adin Tooker report on this Form 4?

Adin M. Tooker reported exercising 8,307 stock options into Hartford Insurance Group common stock, then selling 8,307 common shares in an open-market transaction, and receiving a separate grant of 28,982 new stock options, all recorded over February 24–25, 2026.

How many Hartford Insurance Group (HIG) shares did the insider sell?

The filing shows an open-market sale of 8,307 Hartford Insurance Group common shares at a reported price of $140.54 per share. This sale followed the same-day exercise of 8,307 stock options into common stock before the disposition.

Were the HIG insider’s stock sales made under a 10b5-1 trading plan?

Yes. The Form 4 footnotes state the reported transaction was executed under a trading plan adopted by Adin M. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, indicating a pre-arranged selling program.

What new equity award did Hartford Insurance Group grant to its president?

On February 24, 2026, Adin M. Tooker received a grant of 28,982 Hartford Insurance Group stock options. The footnotes detail a vesting schedule in which one-third of these options become exercisable each year over three years from the grant date.

How many HIG common shares does the insider hold after these transactions?

Following the reported exercise and sale, the Form 4 lists Adin M. Tooker’s directly owned Hartford Insurance Group common stock at 38,208.27 shares. This figure reflects his remaining equity stake in common shares after the 8,307-share open-market disposition.

What vesting terms apply to the Hartford Insurance Group options in this Form 4?

Footnotes describe several option grants with staggered vesting. For certain awards, one-third becomes exercisable on each of three consecutive anniversaries of the grant date, while others are already fully exercisable as of specified February dates in 2021 through 2025.